MEMPHIS, Tenn. and AUGUSTA, Ga., Jan. 29, 2014 /PRNewswire/ -- Germantown Private Psychiatry PLLC and NEBA® Health, LLC announce today that Dr. Arif Mirza, MD Child Psychiatrist & Medical Director of Germantown Private Psychiatry PLLC have become NEBA partners and now offer the only FDA approved brainwave-based ADHD assessment aid.
The NEBA ADHD Test can be scheduled at our office located at 7505 Capital Dr., Germantown, TN 38138. To better serve families, a special Saturday clinic is also available; please refer to our website for details.
About Arif Mirza, MD & Germantown Private Psychiatry PLLC
Germantown Private Psychiatry PLLC has provided top quality care to children, teens and adults in the mid-south region. Dr. Mirza, a highly trained Child, Adolescent & Adult Psychiatrist is board certified by American Board of Psychiatry & Neurology. Our treatment philosophy ensures careful integration from the fields of neuroscience, psychology, psychiatry, child development and education for diagnosis and treatment. "We've partnered with NEBA Health to assist us with our patients presenting with attention and behavior problems. We use the best tools possible to aid with our diagnosis," said Dr. Mirza.
NEBA is a 15 to 20 minute test that integrates an EEG biomarker for ADHD into the clinical setting. Using NEBA, clinicians can significantly reduce the number of patients receiving ADHD treatment and management as the initial focus when another condition would potentially be the primary diagnosis. In the FDA validation study, NEBA reduced the potential for over-diagnosis from 34% to 3%. NEBA also provides confirmatory support for ADHD with an accuracy of 92%. Clinicians conduct their evaluation as in their regular practice using their usual assessment tools. NEBA uses EEG to separate ADHD patients into biomarker-based groups with clinical differences that allow validated recommendations to be offered to the clinicians.
Dr. Steve Snyder, Vice President of Research and Development said, "NEBA can help the clinician to confirm ADHD as primary diagnosis, and can help the clinician to determine whether ADHD-like symptoms may be better explained by another primary condition. A clinician using NEBA is more likely to converge upon diagnostic evaluation results of a multidisciplinary team."
About NEBA Health
NEBA® Health develops diagnostic tools to help clinicians improve the lives of children and families. We developed the first FDA approved Neuropsychiatric Interpretative Electroencephalograph Assessment Aid (NIEA) -- named NEBA®. We have a variety of programs including NEBA-Cares to provide need-based assistance. We have ongoing work in ADHD, depression and dementia. NEBA is an ISO 13485 registered medical device developer. We are cleared for marketing in the USA as (K112711), CE marked, and Health Canada licensed.
SOURCE Germantown Private Psychiatry PLLC